Page 27 - Plastics News March 2021
P. 27

FeAtures




          interior materials. A single test such as UV resistance and   injection molding and foam-in-place instrument panels,
          heat aging can typically take up to 21 days to complete,   doors, and consoles; then do final assembly and ship the
          but we were able to have prototype parts sent to FCA   finished product to the customer.
          within a month of kicking off the project.”
                                                                Could Protect Mass Transit, Medical Devices & Flooring
          CpK and a Canadian University had to develop their own   According to Farrar, the additive has many applications
          biosafety lab to test this new additive.
                                                                outside of automotive. “Our patent has 80 claims, with
          One  of  the  challenges  the  team  faced  was  anti-viral   the majority of the focus outside of automotive. It could
          testing. Most Canadian labs don’t have the infrastructure   be used for public transit (buses, subways, planes, etc.),
          to handle Biosafety Level 3 viral pathogens like SARS-  commercial  spaces  (flooring,  door  handles,  etc),  and
          CoV-2.  CpK  was  able  to  contract  the  ImPaKT  Facility   in medical devices.” The company is undertaking the
          at  Western  University’s  Schulich  School  of  Medicine  &   approval process from Canada’s PMRA and the U.S. EPA for
          Dentistry  in London, Ont., to collaborate and perform   use in auto-interior components. Says Farrar, “This ensures
          testing. The ImPaKT Facility is a one-of-a-kind CL2+/  that we have enough data to support our product claims.
          CL3 facility with advanced in vivo imaging capabilities,   Given that we have been testing on the SARS-CoV-2 strain
          which allow researchers and industry to develop tools and   directly, we don’t feel that there will be any issue with
          methods to better understand the progression of infectious   our data. Most labs do not have this virus strain, so the
          diseases, identify effective antimicrobial agents, develop   lab we chose was strategic.”
          diagnostic reagents to characterize hidden reservoirs of   CpK is uniquely structured to meet FCA’s challenge as
          pathogens, and achieve early and accurate detection of   it has the ability to develop, test and manufacture raw
          infections. CpK is uniquely structured to meet a challenge   materials; use them for injection molding and foam-in-
          like this as it has the ability to develop, test, and   place instrument panels, doors, and consoles; and do final
          manufacture raw materials; use those raw materials for
                                                                assembly and ship finished product.












































                                                                                  27    March 2021     Plastics News
   22   23   24   25   26   27   28   29   30   31   32